- Home
- CATX vs TALK Comparison
CATX vs TALK Comparison
Compare CATX & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATX | TALK |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.4M | 656.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CATX | TALK |
|---|---|---|
| Price | $4.96 | $4.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $12.20 | $5.90 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.10 |
| Revenue Next Year | N/A | $18.15 |
| P/E Ratio | ★ N/A | $155.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $2.22 |
| 52 Week High | $6.16 | $5.18 |
Technical Indicators
Market Signals| Indicator | CATX | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 60.29 |
| Support Level | $3.24 | $2.52 |
| Resistance Level | $5.39 | $5.18 |
| Average True Range (ATR) | 0.41 | 0.30 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 33.21 | 71.77 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.